Evidence map›Paper›PMID 32765191›Full record

ArticleBiological procedures online2020

Isolation and Quantification of Blood Apoptotic Bodies, a Non-invasive Tool to Evaluate Apoptosis in Patients with Ischemic Stroke and Neurodegenerative Diseases.

Gemma Serrano-Heras, Inmaculada Díaz-Maroto, Beatriz Castro-Robles, Blanca Carrión, Ana B Perona-Moratalla, Julia Gracia, Sandra Arteaga, Francisco Hernández-Fernández, Jorge García-García, Oscar Ayo-Martín and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biological procedures online, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Harnessing artificial intelligence for engineering extracellular vesicles.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Frontiers in cell and developmental biology · 2024
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Gemma Serrano-HerasResearch Unit, Complejo Hospitalario Universitario de Albacete, Laurel, s/n, CP: 02008, Albacete, Spain.ORCID 0000-0001-9368-4832
Inmaculada Díaz-MarotoDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Beatriz Castro-RoblesResearch Unit, Complejo Hospitalario Universitario de Albacete, Laurel, s/n, CP: 02008, Albacete, Spain.
Blanca CarriónResearch Unit, Complejo Hospitalario Universitario de Albacete, Laurel, s/n, CP: 02008, Albacete, Spain.
Ana B Perona-MoratallaDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Julia GraciaDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Sandra ArteagaResearch Unit, Complejo Hospitalario Universitario de Albacete, Laurel, s/n, CP: 02008, Albacete, Spain.
Francisco Hernández-FernándezDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Jorge García-GarcíaDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Oscar Ayo-MartínDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Tomás SeguraDepartment of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Complejo Hospitalario Universitario de Albacete · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImproper regulation of apoptosis has been postulated as one of the main factors that contributes to the etiology and/or progression of several prevalent diseases, including ischemic stroke and neurodegenerative pathologies. Consequently, in the last few years, there has been an ever-growing interest in the in vivo study of apoptosis. The clinical application of the tissue sampling and imaging approaches to analyze apoptosis in neurological diseases is, however, limited. Since apoptotic bodies are membrane vesicles that are released from fragmented apoptotic cells, it follows that the presence of these vesicles in the bloodstream is likely due to the apoptotic death of cells in tissues. We therefore propose to use circulating apoptotic bodies as biomarkers for measuring apoptotic death in patients with ischemic stroke and neurodegenerative diseases.

resultsSince there is no scientific literature establishing the most appropriate method for collecting and enumerating apoptotic bodies from human blood samples. Authors, here, describe a reproducible centrifugation-based method combined with flow cytometry analysis to isolate and quantify plasma apoptotic bodies of patients with ischemic stroke, multiple sclerosis, Parkinson's disease and also in healthy controls. Electron microscopy, dynamic light scattering and proteomic characterization in combination with flow cytometry studies revealed that our isolation method achieves notable recovery rates of highly-purified intact apoptotic bodies.

conclusionsThis easy, minimally time consuming and effective procedure for isolating and quantifying plasma apoptotic bodies could help physicians to implement the use of such vesicles as a non-invasive tool to monitor apoptosis in patients with cerebrovascular and neurodegenerative diseases for prognostic purposes and for monitoring disease activity.

Indexed as

ApoptosisApoptotic bodiesBiomarkersIschemic strokeMultiple sclerosisParkinson’s diseasePlasma samples

Identifiers

PMID32765191
PMCPMC7395395
OpenAlexW3046811038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.